Autumn 2018


Alfred Wins INVaR Poster Prize

Alfred Ho WinnerThe Barclay lab is a member of the Imperial Network for Vaccine Research (INVaR), a hub for academia and industry to network and collaborate on vaccine development and engineering, pathogen biology, immunology, epidemiology, health economics and tackling global health challenges. At the INVaR inauguration held on 24 October 2018, Alfred Ho, an Imperial-HKU Joint PhD student, was awarded best poster prize for his work on investigating the potential for antigenic escape from broadly neutralising antibodies in the highly-conserved HA stalk domain of pandemic H1N1 influenza virus.


Events to mark the 1918 influenza pandemic.

Museum Day Out2018 marks 100 years since the 1918 influenza pandemic also known as 'Spanish Flu.' Find out more about the 1918 flu in this Imperial podcast or in this BBC article. The Barclay lab also took a trip out to the Florence Nightingale Museum to see the 1918 Spanish Flu Exhibition. It was very enjoyable and informative too!


Summer 2018


The Barclay Lab Group complete the Seven Sisters Challenge in aid of Action Medical Research for Children.

Seven Sisters Challenge

On the 10 July, all of the members of the Barclay Lab Group completed the gruelling 13-mile Seven sisters route along the south coast from Eastbourne to Seaford. We completed this challenge in aid of the children's charity Action Medical Research which is dedicated to improving the health of babies and children. A big thank you to everyone who helped us to reach our fundraising target.                                                                                                                                                                         

 

 


Dr Jason Long and Dr Daniel Goldhill presented their research at the 2018 Negative Strand Virus Conference in Verona

Dr Jason Long and Dr Daniel Goldhill

Jason and Daniel presented their research at the Negative Strand Virus Conference in Verona. Jason's talk was titled "Binding to ANP32 is required but not sufficient for influenza A virus polymerase activity."  Daniel spoke about his research into resistance to favipiravir.